Pregabalin augmentation in treatment resistant obsessive compulsive disorder:a randomized double blind controlled clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181225042113N1

Enrollment

Registered

2019-03-05

Start date

2018-12-22

Completion date

Unknown

Last updated

2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive compulsive disorder. Obsessive-compulsive disorder

Interventions

Intervention 1: Intervention group :continue get serteralin and add pregabalin (start with 75mg and slowly increase to 150mg for 12weeks. We assese numbers of yale brown scale by paired T test. Inter

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patient with impression of OCD according to DSM-V Yale brown scale>15 Without any other psychiatric problem except OCD Patient without medical problem Do not use any substance

Exclusion criteria

Exclusion criteria: Pregnancy Lactation During psychotherapy

Design outcomes

Primary

Measure	Time frame
Number of yale brown scal. Timepoint: Before give pregabalin and after 12 week done yale brown scale. Method of measurement: Yale brown scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehrnoosh Ghaedsharaf

Shiraz University of Medical Sciences

Mehrghaedsharaf@gmail.com+98 71 3647 9366

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026